The Indian pharmaceutical contract manufacturing firm has leased space at Bruntwood SciTech’s Alderley Park, to serve as its first European laboratory.
Sai Life Sciences has signed a 14-year lease with Bruntwood SciTech, the joint venture between the Manchester-based developer and fund manager Legal & General, and plans to move into the space this summer following a refurbishment.
The company, which is in the middle of significant works to convert the space into a chemistry lab with a focus on molecule processing, is one of India’s fastest growing firms in the sector.
Contract development and management involves the provision of a range of services from drug development to manufacturing on behalf of pharmaceutical clients. Sai Life Sciences works with the world’s top 10 pharma companies and says it aims to support the launch of 25 new medicines by 2025.
It will join other medical organisations, including the Medicines Discovery Catapult, AMR Centre and several start-ups and large biotechnology firms at the 1m sq ft life sciences and business campus at Nether Alderley, between Macclesfield and Knutsford.
Alderley Park is been open during lockdown as some of its facilities were made available for coronavirus testing as part of the Government’s drive to set up dedicated temporary Covid-19 laboratories across the country.
Andrew Kennedy, vice-president and Manchester site head at Sai Life Sciences, said: “Alderley Park’s world-class facilities make it the perfect place for us to set up a centre of excellence for [small molecule process development], which will have a positive and lasting impact on the future of healthcare.
“it’s important that we’re part of a community dedicated to nurturing science and innovation, and with access to some of the finest pharmaceutical talent.”
Dr Kath Mackay, managing director of Bruntwood SciTech Alderley Park, added: “The arrival of Sai Life Sciences…brings contract development and manufacturing to Alderley Park, cementing our position as a global destination for all things life science.”